Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D
Restricted accessResearch articleFirst published online April, 2015
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D
Vitamin D receptor is constitutively expressed on the lymphocyte surface. Recent studies highlight that vitamin D may exert actions on T-cells, inhibiting Th1 and Th17 response and enhancing Th2 and T-regulatory (T-reg) function.
Methods
Thirty-four patients with systemic lupus erythematosus (SLE) were randomly enrolled in a two-year prospective study. In the first year, 16 patients were supplemented with an intensive regimen of cholecalciferol (IR) (300.000 UI of cholecalciferol at baseline and 50.000 UI/monthly as maintenance, 850.000 UI annually), whereas 18 with a standard regimen (SR) (25.000 UI of cholecalciferol monthly, 300.000 UI annually). During the second year, patients were switched to the other arm of treatment. Phenotypic analysis of peripheral T lymphocyte and the quantification of cytokine production from peripheral blood mononuclear cells (PBMCs) were evaluated by flow cytometry.
Results
At baseline, no significant difference between the two groups emerged among main T-cell subtypes. Over two years of treatment, we saw an increase in the number of T-reg cells, in the total amount of CD4+CD45RA+CCR7− T-cells, whereas a significant reduction of CD8+CD28− T-cells was observed. In addition, the analysis of PBMCs from eight patients following the IR showed the reduction of the IFN-γ/IL-4 ratio (p = 0.01) among CD8+ T-cells after 12 months.
Conclusions
After a long-term of monthly treatment with vitamin D in SLE patients, an enhancement of T-reg cells and the production of Th2 cytokines should be expected.
TsokosGC. Systemic lupus erythematosus. N Engl J Med2011; 365: 22–22.
2.
ScheineckerCZwölferBKöllerMMännerGSmolenJS. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis Rheum2001; 44: 856–865.
3.
MakAKowNY. The pathology of T cells in systemic lupus erythematosus. J Immunol Res2014; 2014: 419029–419029.
4.
WongCKHoCYLiEKLamCW. Elevation of proinflammatory cytokine (lL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus2000; 9: 589–593.
5.
BonelliMSmolenJSScheineckerC. Treg and lupus. Ann Rheum Dis2010; 69Suppl 1): i65–i66.
6.
SallustoFLenigDFörsterRLippMLanzavecchiaA. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature1999; 401: 708–712.
7.
StriogaMPasukonieneVCharaciejusD. CD8+CD28− and CD8+CD57+ T cells and their role in health and disease. Immunology2011; 134: 17–32.
8.
ScarsiMZiglioliTAiròP. Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritis. J Rheumatol2011; 38: 2105–2111.
9.
Ruiz-IrastorzaGEgurbideMVOlivaresNMartinez-BerriotxoaAAguirreC. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford)2008; 47: 920–923.
10.
OrbachHZandman-GoddardGAmitalH. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D and TPA levels in autoimmune diseases. Ann N Y Acad Sci2007; 1109: 385–400.
11.
CutoloMPizzorniCSulliA. Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun Rev2011; 11: 84–87.
12.
Van EttenEMathieuC. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol2005; 97: 93–101.
13.
BoonstraABarratFJCrainCHeathVLSavelkoulHFO’GarraA. 1 alpha, 25-dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. J Immunol2001; 167: 4974–4980.
14.
PennaGAdoriniL. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol2000; 164: 2405–2411.
15.
GregoriSGiarratanaNSmiroldoSUskokovicMAdoriniL. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes2002; 51: 1367–1374.
16.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
17.
Romero-DiazJIsenbergDRamsey-GoldmanR. Measures of adult systemic lupus erythematosus: Updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). Arthritis Care Res (Hoboken)2011; 63Suppl 11): S37–S46.
18.
AndreoliLDall’AraFPiantoniS. A 24-month, prospective study on the efficacy and safety of two different regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus. Lupus2015; 24: 499–506.
19.
HolickMFBinkleyNCBischoff-FerrariHA. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab2011; 96: 1911–1930.
20.
HuismanAMWhiteKPAlgraA. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol2001; 28: 2535–2539.
21.
MokCC. Vitamin D and systemic lupus erythematosus: an update. Expert Rev Clin Immunol2013; 9: 453–463.
22.
AttarSMSiddiquiAM. Vitamin D deficiency in patients with systemic lupus erythematosus. Oman Med J2013; 28: 42–47.
23.
MokCCBirminghamDJHoLYHerbertLASongHRovinBH. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus2012; 21: 36–42.
24.
StagiSCavalliLBertiniF. Vitamin D levels in children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus: a cross-sectional study. Lupus2014; 23: 1059–1065.
25.
Abou-RayaAAbou-RayaSHelmiiM. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol2013; 40: 265–272.
26.
PetriMBelloKJFangHMagderLS. Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum2013; 65: 1865–1871.
27.
LeitnerJDrobitsKPicklWFMajdicOZlabingerGSteinbergerP. The effects of cyclosporine A and azathioprine on human T cells activated by different co-stimulatory signals. Immunol Lett2011; 140: 74–80.
28.
GoronzyJJMattesonELFulbrightJW. Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum2004; 50: 43–54.
29.
TulunayAYavuzSDireskeneliHEksioglu-DemiralpE. CD8+CD28– suppressive T cells in systemic lupus erythematosus. Lupus2008; 17: 630–637.
30.
HarariAVallelianFPantaleoG. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur J Immunol2004; 34: 3525–3533.
31.
KochSLarbiADerhovanessianEOzcelikDNaumovaEPawelecG. Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing2008; 5: 6–6.
32.
DrozdenkoGScheelTHeineGBaumgrassRWormM. Impaired T cell activation and cytokine production by calcitriol-primed human B cells. Clin Exp Immunol2014; 178: 364–372.
33.
BarratFJCuaDJBoonstraA. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med2002; 195: 603–616.
34.
UngerWWLabanSKleijwegtFSVan der SlikARRoepBO. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol2009; 39: 3147–3159.
35.
KhooALJoostenIMichelsM. 1,25-dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells. Immunology2011; 134: 459–468.
36.
TerrierBDerianNSchoindreY. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther2012; 14: R221–R221.
37.
LeeJHWangLCLinYTYangYHLinDTChiangBL. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in pediatric patients with systemic lupus erythematosus. Immunology2006; 117: 280–286.
38.
BlancoPPitardVViallardJFTaupinJLPellegrinJLMoreauJF. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum2005; 52: 201–211.
39.
YangJYangXZouHChuYLiM. Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus. Rheumatology (Oxford)2011; 50: 1366–1372.
